SCHEMBL12495826

SCHEMBL12495826

CCCCc1c(-c2ccsc2)nc(N)nc1-c1cccs1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADK P55263 2/20 0.44
▸ MEN1 O00255 5/20 0.43
▸ KMT2A Q03164 5/20 0.43
▸ ALDH1A1 P00352 4/20 0.43
▸ HPGD P15428 3/20 0.43
▸ MAPT P10636 2/20 0.43
▸ POLB P06746 1/20 0.43
▸ KDM4E B2RXH2 3/20 0.42
▸ ADORA2A P29274 4/20 0.42
▸ ADORA1 P30542 3/20 0.41
▸ ADORA2B P29275 1/20 0.41
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ DHFR P00374 1/20 0.39
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12495825 0.90 ADK (0.51) ADKMEN1KMT2AALDH1A1HPGD
SCHEMBL16223017 0.88 ADORA2A (0.47) ADKMEN1KMT2AALDH1A1HPGD
SCHEMBL12495868 0.88 ADK (0.46) ADKMEN1KMT2AALDH1A1HPGD
SCHEMBL12495847 0.86 ADORA2A (0.55) ADKMEN1KMT2AALDH1A1HPGD
SCHEMBL21313192 0.85 ADORA2A (0.45) ADKALDH1A1MAPTADORA2AADORA1
SCHEMBL16223135 0.85 ADORA2A (0.58) ALDH1A1MAPTADORA2AADORA1DHFR
SCHEMBL12496530 0.83 KDM4E (0.47) ADKMEN1KMT2AALDH1A1HPGD
SCHEMBL12495540 0.81 ADK (0.46) ADKMEN1KMT2AALDH1A1HPGD
SCHEMBL21313191 0.81 ADORA2A (0.45) ADKMEN1KMT2AALDH1A1HPGD
SCHEMBL12496003 0.81 CYP3A4 (0.50) ADKMEN1KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3195867-B1 PYRIMIDINE COMPOUNDS INHIBITING THE FORMATION OF NITRIC OXIDE AND PROSTAGLANDIN E2, METHOD OF PRODUCTION THEREOF AND USE THEREOF USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CR V V I (CZ) 2019-09-04 — — EP claimed
US-8883798-B2 Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin E2, method of production thereof and use thereof USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CR, v.v.i. (CZ) 2014-11-11 — — US claimed
EP-2680847-A1 PYRIMIDINE COMPOUNDS INHIBITING THE FORMATION OF NITRIC OXIDE AND PROSTAGLANDIN E2, METHOD OF PRODUCTION THEREOF AND USE THEREOF Ustav Organicke Chemie A Biochemie Akademie Ved Cr, v.v.i. (CZ) 2014-01-08 — — EP disclosed
WO-2012116666-A1 PYRIMIDINE COMPOUNDS INHIBITING THE FORMATION OF NITRIC OXIDE AND PROSTAGLANDIN E2, METHOD OF PRODUCTION THEREOF AND USE THEREOF USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CR, v.v.i. (CZ) 2012-09-07 — — WO disclosed
Send feedback